Gynae BT 2017

Survival, median follow-up 60.2 months

HR 0.79 [0.57-1.12], p=0.18

HR 0.77 [0.58-1.03], p=0.078

5 yr OS: 82% (CTRT) versus 77% (RT)

5 yr FFS: 76% (CTRT) versus 69% (RT)

6/2/2017

PORTEC-3 results

De Boer et al, ASCO 2017